Lumos Diagnostics Holdings Limited (LDXHF)

USD 0.02

(0.0%)

Operating Expenses Summary of Lumos Diagnostics Holdings Limited

  • Lumos Diagnostics Holdings Limited's latest annual operating expenses in 2024 was 7.09 Million USD , up 22.54% from previous year.
  • Lumos Diagnostics Holdings Limited's latest quarterly operating expenses in 2024 FY was 4.15 Million USD , down -28.24% from previous quarter.
  • Lumos Diagnostics Holdings Limited reported a annual operating expenses of 5.79 Million USD in annual operating expenses 2023, down -77.31% from previous year.
  • Lumos Diagnostics Holdings Limited reported a annual operating expenses of 25.52 Million USD in annual operating expenses 2022, up 117.99% from previous year.
  • Lumos Diagnostics Holdings Limited reported a quarterly operating expenses of 3.52 Million USD for 2024 Q1, up 68.64% from previous quarter.
  • Lumos Diagnostics Holdings Limited reported a quarterly operating expenses of 2.34 Million USD for 2024 Q2, down -33.33% from previous quarter.

Annual Operating Expenses Chart of Lumos Diagnostics Holdings Limited (2024 - 2018)

Historical Annual Operating Expenses of Lumos Diagnostics Holdings Limited (2024 - 2018)

Year Operating Expenses Operating Expenses Growth
2024 7.09 Million USD 22.54%
2023 5.79 Million USD -77.31%
2022 25.52 Million USD 117.99%
2021 11.71 Million USD -11.29%
2020 13.2 Million USD 165.09%
2019 4.97 Million USD 127.82%
2018 2.18 Million USD 0.0%

Peer Operating Expenses Comparison of Lumos Diagnostics Holdings Limited

Name Operating Expenses Operating Expenses Difference
American Bio Medica Corporation 1.04 Million USD -576.644%
Arrayit Corporation 6.19 Million USD -14.529%
Atlantic International Corp. 5.57 Million USD -27.244%
Biocept, Inc. 29.4 Million USD 75.858%
Bioqual, Inc. 7.44 Million USD 4.709%
CardioGenics Holdings Inc 772.14 Thousand USD -819.261%
DermTech, Inc. 104.01 Million USD 93.176%
Global WholeHealth Partners Corporation - USD -Infinity%
Hangzhou Tigermed Consulting Co., Ltd. 166.5 Million USD 95.737%
HTG Molecular Diagnostics, Inc. 22.62 Million USD 68.626%
iMD Companies, Inc. 151.8 Thousand USD -4575.612%
IDenta Corp. 662.97 Thousand USD -970.629%
Interpace Biosciences, Inc. 20.23 Million USD 64.917%
Integrative Health Technologies, Inc. 38.88 Thousand USD -18155.703%
InVitro International 661.32 Thousand USD -973.301%
Many Bright Ideas Technologies Inc. 58.11 Thousand USD -12114.345%
Medical Imaging Corp. 1.91 Million USD -271.202%
NovelStem International Corp. 3.53 Million USD -100.633%
Optigenex Inc. 1.28 Million USD -451.143%
PharmChem, Inc. 2.93 Million USD -142.151%
Proteome Sciences plc 3.26 Million USD -117.197%
Response Genetics, Inc 25.31 Million USD 71.966%
Rennova Health, Inc. 7.67 Million USD 7.551%
RushNet, Inc. 1.78 Million USD -296.687%
ScreenPro Security Inc. 3.23 Million USD -119.148%
Stella Diagnostics Inc. 11.42 Million USD 37.884%
StageZero Life Sciences Ltd. 7.34 Million USD 3.337%
Todos Medical Ltd. 14.05 Million USD 49.509%